{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "19167131", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20210717", "reporttype": "2", "serious": "2", "receivedateformat": "102", "receivedate": "20210422", "receiptdateformat": "102", "receiptdate": "20210422", "fulfillexpeditecriteria": "2", "companynumb": "US-GW PHARMA-202104USGW01837", "duplicate": "1", "reportduplicate": { "duplicatesource": "GW PHARMA", "duplicatenumb": "US-GW PHARMA-202104USGW01837" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "reaction": [ { "reactionmeddraversionpt": "24.0", "reactionmeddrapt": "Condition aggravated", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "EPIDIOLEX", "drugstructuredosagenumb": "250", "drugstructuredosageunit": "003", "drugdosagetext": "13.15 MG/KG/DAY, 250 MILLIGRAM, QD", "drugdosageform": "ORAL SOLUTION", "drugadministrationroute": "048", "drugindication": "LENNOX-GASTAUT SYNDROME", "drugstartdateformat": "602", "drugstartdate": "2020", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CANNABIDIOL" }, "openfda": { "application_number": [ "NDA210365" ], "brand_name": [ "EPIDIOLEX" ], "generic_name": [ "CANNABIDIOL" ], "manufacturer_name": [ "Jazz Pharmaceuticals, Inc." ], "product_ndc": [ "70127-100" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CANNABIDIOL" ], "rxcui": [ "2058900", "2058906" ], "spl_id": [ "1eb7ac65-8df5-4a4a-9156-802cfaa92b06" ], "spl_set_id": [ "8bf27097-4870-43fb-94f0-f3d0871d1eec" ], "package_ndc": [ "70127-100-01", "70127-100-10", "70127-100-06", "70127-100-60" ], "nui": [ "M0003267", "N0000187062", "N0000185504", "N0000182140", "N0000191278", "N0000191273", "N0000182138", "N0000182139", "N0000187064" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]" ], "unii": [ "19GBJ60SN5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CLOBAZAM.", "drugdosagetext": "UNK", "drugadministrationroute": "065", "drugindication": "LENNOX-GASTAUT SYNDROME", "activesubstance": { "activesubstancename": "CLOBAZAM" }, "openfda": { "application_number": [ "NDA210833", "ANDA213404", "ANDA211711", "ANDA210978", "ANDA213110", "ANDA214404", "ANDA208819", "ANDA209795", "ANDA209796", "ANDA210545", "ANDA209718", "ANDA210039", "ANDA212714", "NDA203993", "NDA202067", "ANDA213039", "ANDA209687" ], "brand_name": [ "SYMPAZAN", "CLOBAZAM", "ONFI" ], "generic_name": [ "CLOBAZAM" ], "manufacturer_name": [ "Aquestive Therapeutics", "Novadoz Pharmaceuticals LLC", "Micro Labs Limited", "Sun Pharmaceutical Industries, Inc.", "Chartwell RX, LLC", "Aurobindo Pharma Limited", "Bionpharma Inc.", "Camber Pharmaceuticals, Inc.", "NorthStar RxLLC", "Lupin Pharmaceuticals, Inc.", "Amneal Pharmaceuticals NY LLC", "Ascend Laboratories, LLC", "Lundbeck Pharmaceuticals LLC", "Upsher-Smith Laboratories, LLC" ], "product_ndc": [ "10094-205", "10094-210", "10094-220", "72205-047", "72205-048", "42571-315", "42571-316", "51672-4227", "62135-527", "59651-401", "69452-116", "31722-639", "31722-640", "16714-087", "16714-887", "16714-888", "68180-157", "68180-158", "69238-1305", "69238-1306", "69238-1535", "67877-664", "67877-665", "67877-666", "67386-313", "67386-314", "67386-315", "31722-641", "67877-658", "0832-0580", "0832-0581" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLOBAZAM" ], "rxcui": [ "2058253", "2058254", "2058255", "2102713", "2102715", "2102717", "199450", "246172", "1366192", "427538", "1191056", "1191058", "1366196" ], "spl_id": [ "4a004ed9-140a-4054-843c-4e31d42667ec", "3c8a899d-7c67-43d5-9428-0c0d0f9583de", "50d350cb-6640-b3c2-e063-6394a90a397b", "569900df-15bd-52e4-e063-6394a90aaa0b", "181bd7dd-a848-7bc7-e063-6294a90a482c", "df4d6b4b-9864-4c24-92e1-4a72c2863b5f", "27d7f38a-1122-d6bb-e063-6394a90a5cd8", "22eea187-7659-07de-e063-6394a90a5dca", "f649cb16-8cb4-5292-e053-2995a90a04fc", "223818f1-9350-07e9-e063-6294a90ab33a", "ce8d2e9b-0cf3-4206-9523-6f0df27953b8", "182c75a8-797a-457e-915b-c3297e71b43b", "cf085b2b-564e-4109-90e7-1d27fcbca810", "f9dc8ac4-86be-49ab-9c2c-c60658f49d8f", "68dbe31c-2dbe-49ad-8b2e-2cf1b8521167", "556132d3-7f61-e679-e063-6394a90a4528", "1555689f-8f9a-4042-8a94-911e90904dd0", "1e02d082-c325-6bd1-e063-6294a90a14ac" ], "spl_set_id": [ "5e3d8fcb-aa7d-4822-88fc-4f06264c3242", "cf5bb37f-5386-47d3-8cec-d48253d359f6", "721dde68-db83-4dad-8649-8046cb455372", "fd1e63bf-496c-427c-83b7-6acabc00a5e5", "17c3b9db-9e25-4a17-ac45-bcd17ea0360c", "1b5749a1-1c6d-4243-a833-4bfd84f9d5a9", "4b92ac57-25aa-4c00-b062-dee3944b271b", "cf31b8d1-0d19-4529-99b6-1f7366064a3c", "574a3f91-d73e-46bc-b4a1-2388439521fb", "6f94e10e-ee4e-44e1-9c84-16c5d8c9b594", "d9e03a2a-3fea-4c98-ab71-415e6ebda3e0", "6783eaa8-e236-4957-aaa9-b42bf8e709a7", "a526ad73-d3c1-40b7-8e71-426b01cdea27", "a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f", "de03bd69-2dca-459c-93b4-541fd3e9571c", "c9b51794-3cfa-4a34-b5bb-d523b5798c17", "07e0ae51-cc71-427f-83cb-311b7fcc5993", "6da2c381-057b-456a-b57b-464f8b383371" ], "package_ndc": [ "10094-205-01", "10094-205-60", "10094-210-01", "10094-210-60", "10094-220-01", "10094-220-60", "72205-047-91", "72205-048-91", "42571-315-30", "42571-315-90", "42571-315-05", "42571-315-32", "42571-315-11", "42571-315-20", "42571-315-91", "42571-315-01", "42571-316-30", "42571-316-90", "42571-316-32", "42571-316-11", "42571-316-20", "42571-316-91", "42571-316-01", "51672-4227-8", "62135-527-41", "59651-401-12", "69452-116-45", "31722-639-01", "31722-639-31", "31722-640-01", "31722-640-31", "16714-087-01", "16714-887-01", "16714-888-01", "68180-157-06", "68180-157-07", "68180-157-09", "68180-157-01", "68180-157-02", "68180-158-06", "68180-158-07", "68180-158-09", "68180-158-01", "68180-158-02", "69238-1305-1", "69238-1306-1", "69238-1535-2", "67877-665-01", "67877-665-05", "67877-665-33", "67877-666-01", "67877-666-05", "67877-666-33", "67877-664-01", "67877-664-05", "67877-664-33", "67386-314-01", "67386-315-01", "67386-313-21", "31722-641-12", "67877-658-61", "0832-0580-11", "0832-0581-11" ], "nui": [ "N0000175694", "M0002356", "N0000182137", "N0000185506" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]" ], "unii": [ "2MRO291B4U" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VALPROATE SODIUM;VALPROIC ACID", "drugdosagetext": "UNK", "drugadministrationroute": "065", "drugindication": "LENNOX-GASTAUT SYNDROME", "activesubstance": { "activesubstancename": "VALPROIC ACID" } } ] } } ] }